Related Experiment Video
Updated: Jan 16, 2026

06:53
Modeling Primary Bone Tumors and Bone Metastasis with Solid Tumor Graft Implantation into Bone
Published on: September 9, 2020
3.2K
Exploring the Rare Occurrence of Giant Cell Tumour in Distal Tibia
K Parakh-Naman1, N Chauhan2, R Mishra3
1Department of Orthopaedics, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, India.
Malaysian Orthopaedic Journal
|January 15, 2026
Summary
Giant cell tumours (GCT) of the distal tibia are challenging. Surgical resection and reconstruction, including fibular grafting and ankle arthrodesis, achieved pain-free ambulation and stability in three patients.
Area of Science:
- Orthopedic Oncology
- Musculoskeletal Tumors
Background:
- Giant cell tumours (GCT) of the distal tibia are rare, locally aggressive bone lesions.
- The distal tibia's complex anatomy presents unique management challenges and a higher risk of morbidity.
- Effective treatment strategies are crucial for functional recovery and pain relief.
Purpose of the Study:
- To present the clinical course, surgical management, and outcomes of three patients with distal tibial GCT.
- To highlight specific reconstructive techniques for this challenging anatomical location.
- To evaluate the efficacy of treatment in achieving pain-free ambulation and preventing recurrence.
Main Methods:
- Case series of three patients with biopsy-proven distal tibial GCT (two primary, one recurrent).
- Surgical management involved wide-margin tumour resection.
- Reconstruction utilized contralateral fibular strut grafting and ankle arthrodesis with cement and bone graft.
Main Results:
- All patients successfully underwent tumour resection and reconstruction without major intra-operative complications.
- Radiological follow-up confirmed adequate graft union and no evidence of tumour recurrence.
- Patients achieved satisfactory functional outcomes and pain relief.
Conclusions:
- Surgical resection and reconstruction are effective treatments for distal tibial GCT.
- Techniques like fibular grafting and ankle arthrodesis can restore structural integrity and function.
- Long-term surveillance is essential to monitor for recurrence and potential complications.
Related Concept Videos
Bones of the Lower Limb: Tibia and Fibula
8.8K
The tibia is the main weight-bearing bone of the lower leg. It is larger than the fibula with which it is paired. The tibia is also the second longest bone in the body and is located right below the skin. The proximal end of the tibia forms the medial and the lateral condyle, which articulates with the condyles of the femur to form the knee joint. Between the articulating surfaces is the irregular elevated area known as the intercondylar eminence that serves as the inferior attachment point for...
8.8K
Bones of the Lower Limb: Femur and Patella
4.8K
The femur is the body's longest and strongest bone spanning the thigh region. Its head articulates with the acetabulum of the hip bone to form the hip joint. A minor indentation on the medial side of the femoral head, called the fovea capitis, serves as the site of attachment for the ligament of the head of the femur. This weak ligament spans the femur and acetabulum and supports the hip joint. The narrowed region below the head is the neck of the femur. The inclination angle between the...
4.8K
The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K